Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(10)
Cell Growth
Cell Proliferation
Enzyme Activity
Growth Inhibition
Immunohistochemi...
Mouse Model
Pancreatic Cancer
Pancreatic Carcinoma
Tumor Cells
Tumor Growth
Subscribe
Academic
Publications
cis -Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice
cis -Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice,10.1007/s00384-010-0946-1,International Journal of Colorectal Disease,Diet
Edit
cis -Hydroxyproline-mediated pancreatic carcinoma growth inhibition in mice
BibTex
|
RIS
|
RefWorks
Download
Dietrich Sturm
,
Claudia Maletzki
,
Dagmar Braun
,
Joerg Emmrich
Purpose This study addressed the question of whether the collagen metabolism modulator cis-4-Hydroxy-l-proline (CHP) is applicable for potential use as a therapeutic inhibitor of
pancreatic carcinoma
cell growth. Methods Cell proliferation, as well as quantification of apoptosis of murine Panc02 cells, was assessed after CHP treatment. Supplementary, the effect of CHP on
tumor growth
was examined in the subcutaneous Panc02 model in vivo. Mice received daily intraperitoneal injections of CHP (300, 400, and 500 mg/kg bw). In addition to the assessment of systemic parameters (blood count,
enzyme
activities), histology (HE) and
immunohistochemistry
(Ki-67) were performed from resected tumor specimens. Results Like reduction of metabolic activity, CHP also induced inhibition of
cell growth
in a dose-dependent manner, with however only slight increases in apoptosis. In vivo treatment of Panc02 tumors with CHP resulted in pronounced delay of
tumor growth
and decreases in tumor cell proliferation. Moreover, these effects were accompanied by a massive systemic leukocytosis as well increased leukocyte infiltration into the tumors subsequent to CHP therapy. Conclusions CHP inhibits the proliferation of Panc02
tumor cells
in a dose-dependent manner both in vitro and in vivo. Our presented data show that modulation of the collagen metabolism is an interesting strategy for treatment of pancreatic carcinoma.
Journal:
International Journal of Colorectal Disease - INT J COLORECTAL DIS
, vol. 25, no. 8, pp. 921-929, 2010
DOI:
10.1007/s00384-010-0946-1
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
www.springerlink.com
)
(
www.springerlink.com
)
(
www.springerlink.com
)
(
www.springerlink.com
)
More »
References
(15)
Intrinsic resistance to anticancer agents in the murine pancreatic adenocarcinoma PANC02
(
Citations: 5
)
Teresa S. Priebe
,
Edward N. Atkinson
,
Bih-Fang Panl
,
J. Arly Nelson
Journal:
Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL
, vol. 29, no. 6, pp. 485-489, 1992
Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer
(
Citations: 39
)
T. Aikawa
Journal:
Molecular Cancer Therapeutics - MOL CANCER THER
, vol. 5, no. 5, pp. 1108-1116, 2006
Tumor-stroma interactions in pancreatic ductal adenocarcinoma
(
Citations: 58
)
D. Mahadevan
,
D. D. Von Hoff
Journal:
Molecular Cancer Therapeutics - MOL CANCER THER
, vol. 6, no. 4, pp. 1186-1197, 2007
Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer
(
Citations: 40
)
M. H. Kulke
,
L. S. Blaszkowsky
,
D. P. Ryan
,
J. W. Clark
,
J. A. Meyerhardt
,
A. X. Zhu
,
P. C. Enzinger
,
E. L. Kwak
,
A. Muzikansky
,
C. Lawrence
,
C. S. Fuchs
Journal:
Journal of Clinical Oncology - J CLIN ONCOL
, vol. 25, no. 30, pp. 4787-4792, 2007
Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model
(
Citations: 10
)
C Maletzki
,
M Linnebacher
,
B Kreikemeyer
,
J Emmrich
Journal:
Gut
, vol. 57, no. 4, pp. 483-491, 2007